Catalyst Wire Dossier Catalyst Wire Dossier

Etrolizumab

etrolizumab · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Etrolizumab, covering 2016-11-02 to 2024-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 [Phase 3]

See pricing